Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
273 cases, 18.
I · Intervention 중재 / 시술
hepatectomy or ablation
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
However, this advanced liver interventional care is not equally distributed among patient populations. Significant socioeconomic and demographic disparities exist in the receipt of local liver interventional management among patients with CRLM and require further exploration to improve resource allocation.
[BACKGROUND] Up to 25% of patients with colorectal cancer present with liver metastases (CRLM), and 50% develop metastases over time.
- p-value p<0.001
- 95% CI 0.85-0.99
APA
Martinez AE, Webber A, et al. (2026). Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19483-7
MLA
Martinez AE, et al.. "Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.." Annals of surgical oncology, 2026.
PMID
41832361 ↗
Abstract 한글 요약
[BACKGROUND] Up to 25% of patients with colorectal cancer present with liver metastases (CRLM), and 50% develop metastases over time. Surgical and ablative management of CRLM can be curative, but certain demographic and socioeconomic factors disproportionately hinder vulnerable patient populations from receiving advanced local therapies.
[METHODS] We queried the 2011-2021 National Cancer Database for cases of CRLM. We explored patient and facility characteristics associated with receipt of local intervention versus no intervention for metastatic liver lesions.
[RESULTS] Of 72,273 cases, 18.0% underwent hepatectomy or ablation. Controlling for patient- and center-level factors, non-Hispanic Black and Hispanic/Latino patients were less likely to undergo liver intervention than were non-Hispanic white patients (odds ratio [OR] 0.83 [95% confidence interval (CI) 0.78-0.88] vs. OR 0.92 [95% CI 0.85-0.99]). Patients treated at academic programs had significantly higher odds of liver intervention than did those in community cancer programs (OR 2.24 [95% CI 2.06-2.43]). Patients with private, Medicaid, Medicare, or other government insurance had higher odds of liver intervention than did uninsured patients (OR 2.07 [95% CI 1.86-2.30], OR 1.40 [95% CI 1.24-1.58], OR 1.81 [95% CI 1.61-2.03], OR 2.20 [95% CI 1.81-2.66], respectively). Patients in the highest income quartile were more likely to have liver intervention than those in the lowest quartile (OR 1.18 [95% CI 1.10-1.27]). Patients receiving liver intervention traveled farther than those receiving non-surgical care (p<0.001).
[CONCLUSION] Surgical or local ablative management of CRLM is necessary to achieve cure for appropriately selected patients. However, this advanced liver interventional care is not equally distributed among patient populations. Significant socioeconomic and demographic disparities exist in the receipt of local liver interventional management among patients with CRLM and require further exploration to improve resource allocation.
[METHODS] We queried the 2011-2021 National Cancer Database for cases of CRLM. We explored patient and facility characteristics associated with receipt of local intervention versus no intervention for metastatic liver lesions.
[RESULTS] Of 72,273 cases, 18.0% underwent hepatectomy or ablation. Controlling for patient- and center-level factors, non-Hispanic Black and Hispanic/Latino patients were less likely to undergo liver intervention than were non-Hispanic white patients (odds ratio [OR] 0.83 [95% confidence interval (CI) 0.78-0.88] vs. OR 0.92 [95% CI 0.85-0.99]). Patients treated at academic programs had significantly higher odds of liver intervention than did those in community cancer programs (OR 2.24 [95% CI 2.06-2.43]). Patients with private, Medicaid, Medicare, or other government insurance had higher odds of liver intervention than did uninsured patients (OR 2.07 [95% CI 1.86-2.30], OR 1.40 [95% CI 1.24-1.58], OR 1.81 [95% CI 1.61-2.03], OR 2.20 [95% CI 1.81-2.66], respectively). Patients in the highest income quartile were more likely to have liver intervention than those in the lowest quartile (OR 1.18 [95% CI 1.10-1.27]). Patients receiving liver intervention traveled farther than those receiving non-surgical care (p<0.001).
[CONCLUSION] Surgical or local ablative management of CRLM is necessary to achieve cure for appropriately selected patients. However, this advanced liver interventional care is not equally distributed among patient populations. Significant socioeconomic and demographic disparities exist in the receipt of local liver interventional management among patients with CRLM and require further exploration to improve resource allocation.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- ASO Author Reflections: Nationwide Disparities in Surgical Care of Colorectal Cancer Liver Metastases Persist Despite Advances in Liver-Directed Therapy.
- ASO Visual Abstract: Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
- [Breast pain and fever in a 46-year-old immunosuppressed patient with breast implants].
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- Opposing prognostic roles of tumor-associated and circulating MMP8 in colorectal cancer.
- Copper-enriched zinc peroxides induced cuproptosis through concurrent metabolic and oxidative dysregulation for boosting immunotherapy in colorectal cancer.
- Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II.
- Macrophage deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production.
- Time-Resolved Oxygen Dynamics Reveals Redox-Selective Apoptosis Induced by Cold Atmospheric Plasma in HT-29 Colorectal Cancer Cells.